United Kingdom

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

8 Dec 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Edge Therapeutics reports qtrly loss per share $‍0.37​
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Edge Therapeutics Inc :Edge Therapeutics reports third quarter 2017 financial results.Edge Therapeutics Inc - qtrly loss per share $‍0.37​.  Full Article

Edge Therapeutics reports Q2 loss per share $0.33
Wednesday, 3 Aug 2016 

Edge Therapeutics Inc :Quarterly loss per share $0.33.  Full Article

Edge Therapeutics says received FDA fast-track designation for drug to treat subarachnoid hemorrhage
Friday, 13 May 2016 

Edge Therapeutics Inc : Expects to begin enrollment in mid-2016, a pivotal phase 3 multi-center, multi-national, randomized, double-blind, placebo-controlled, parallel-group study .Edge Therapeutics receives FDA fast track designation for Eg-1962 for the treatment of subarachnoid hemorrhage.  Full Article